acebutolol and Hematologic Neoplasms

acebutolol has been researched along with Hematologic Neoplasms in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	3 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Baron, F; Beguin, Y; De Becker, A; Emonds, MP; Graux, C; Kerre, T; Lewalle, P; Maertens, J; Ory, A; Seidel, L; Theunissen, K; Van Gelder, M; Willems, E; Zachée, P	1
Barrière, J; Bugat, R; Concas, VH; Duvillié, L; Huot-Marchand, P; Laribi, K; Luporsi, E; Morere, JF; Scotté, F; Toledano, A	1
Bugat, R; Duvillié, L; Espié, M; Luporsi, E; Perot, S; Pithois Merli, I; Scotté, F; Spaeth, D; Toledano, A	1

Trials

1 trial(s) available for acebutolol and Hematologic Neoplasms

Article	Year
Non-myeloablative allogeneic hematopoietic cell transplantation following fludarabine plus 2 Gy TBI or ATG plus 8 Gy TLI: a phase II randomized study from the Belgian Hematological Society. Journal of hematology & oncology, 2015, Feb-06, Volume: 8 Topics: Adult; Aged; Allografts; Antilymphocyte Serum; Antineoplastic Agents; Chemoradiotherapy; Disease-Free Survival; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Incidence; Male; Maltose; Middle Aged; Transplantation Conditioning; Vidarabine; Whole-Body Irradiation	2015

Article

Year

Non-myeloablative allogeneic hematopoietic cell transplantation following fludarabine plus 2 Gy TBI or ATG plus 8 Gy TLI: a phase II randomized study from the Belgian Hematological Society.

Journal of hematology & oncology, 2015, Feb-06, Volume: 8

Topics: Adult; Aged; Allografts; Antilymphocyte Serum; Antineoplastic Agents; Chemoradiotherapy; Disease-Free Survival; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Incidence; Male; Maltose; Middle Aged; Transplantation Conditioning; Vidarabine; Whole-Body Irradiation

2015

Other Studies

2 other study(ies) available for acebutolol and Hematologic Neoplasms

Article	Year
Clinical use of ferric carboxymaltose in patients with solid tumours or haematological malignancies in France. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2016, Volume: 24, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Anemia, Iron-Deficiency; Antineoplastic Agents; Female; Ferric Compounds; France; Hematinics; Hematologic Neoplasms; Hemoglobins; Humans; Iron; Male; Maltose; Middle Aged; Prospective Studies; Young Adult	2016
Use of iron sucrose and red blood cell transfusions in anaemic cancer patients in France (OncoFer study). Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2017, Volume: 25, Issue:3 Topics: Adult; Aged; Anemia; Erythrocyte Transfusion; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; France; Glucaric Acid; Hematologic Neoplasms; Hemoglobins; Humans; Male; Maltose; Middle Aged; Neoplasms; Retrospective Studies	2017

Article

Year

Clinical use of ferric carboxymaltose in patients with solid tumours or haematological malignancies in France.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2016, Volume: 24, Issue:1

Topics: Adult; Aged; Aged, 80 and over; Anemia, Iron-Deficiency; Antineoplastic Agents; Female; Ferric Compounds; France; Hematinics; Hematologic Neoplasms; Hemoglobins; Humans; Iron; Male; Maltose; Middle Aged; Prospective Studies; Young Adult

2016

Use of iron sucrose and red blood cell transfusions in anaemic cancer patients in France (OncoFer study).

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2017, Volume: 25, Issue:3

Topics: Adult; Aged; Anemia; Erythrocyte Transfusion; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; France; Glucaric Acid; Hematologic Neoplasms; Hemoglobins; Humans; Male; Maltose; Middle Aged; Neoplasms; Retrospective Studies

2017